6533b839fe1ef96bd12a6df0
RESEARCH PRODUCT
Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis
Mario RizzettoAntonio CraxìG.b. GaetaMaria Chiara ColomboMaurizia Rossana BrunettoG. PalmieriPietro Lamperticosubject
HBsAgHepatologyChronic hepatitisHbeag negativebusiness.industryGenotypeGastroenterologymedicinebusinessInterim analysisVirologyPeginterferon alfa-2amedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2015-02-01 | Digestive and Liver Disease |